Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Journal of clinical oncology

Results: 1-25/635

Authors: LEE SJ ANASETTI C HOROWITZ MM ANTIN JH
Citation: Sj. Lee et al., INITIAL THERAPY FOR CHRONIC MYELOGENOUS LEUKEMIA - PLAYING THE ODDS, Journal of clinical oncology, 16(9), 1998, pp. 2897-2903

Authors: SIMONE JV LYONS J
Citation: Jv. Simone et J. Lyons, THE EVOLUTION OF CANCER CARE FOR CHILDREN AND ADULTS, Journal of clinical oncology, 16(9), 1998, pp. 2904-2905

Authors: KOOPS HS VAGLINI M SUCIU S KROON BBR THOMPSON JF GOHL J EGGERMONT AMM DIFILIPPO F KREMENTZ ET RUITER D LEJEUNE FJ
Citation: Hs. Koops et al., PROPHYLACTIC ISOLATED LIMB PERFUSION FOR LOCALIZED, HIGH-RISK LIMB MELANOMA - RESULTS OF A MULTICENTER RANDOMIZED PHASE-III TRIAL, Journal of clinical oncology, 16(9), 1998, pp. 2906-2912

Authors: HSUEH EC GUPTA RK QI K MORTON DL
Citation: Ec. Hsueh et al., CORRELATION OF SPECIFIC IMMUNE-RESPONSES WITH SURVIVAL IN MELANOMA PATIENTS WITH DISTANT METASTASES RECEIVING POLYVALENT MELANOMA CELL VACCINE, Journal of clinical oncology, 16(9), 1998, pp. 2913-2920

Authors: KEILHOLZ U CONRADT C LEGHA SS KHAYAT D SCHEIBENBOGEN C THATCHER N GOEY SH GORE M DORVAL T HANCOCK B PUNT CJA DUMMER R AVRIL MF BROCKER EB BENHAMMOUDA A EGGERMONT AMM PRITSCH M
Citation: U. Keilholz et al., RESULTS OF INTERLEUKIN-2-BASED TREATMENT IN ADVANCED MELANOMA - A CASE RECORD-BASED ANALYSIS OF 631 PATIENTS, Journal of clinical oncology, 16(9), 1998, pp. 2921-2929

Authors: RAVAUD A CHEVREAU C CANY L HOUYAU P DOHOLLOU N ROCHE H SOUBEYRAN P BONICHON F MIHURA J EGHBALI H TABAH I BUI BN
Citation: A. Ravaud et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH NEUTROPENIC FEVER IS POTENT AFTER LOW-RISK BUT NOT AFTER HIGH-RISK NEUTROPENIC CHEMOTHERAPY REGIMENS - RESULTS OF A RANDOMIZED PHASE-III TRIAL, Journal of clinical oncology, 16(9), 1998, pp. 2930-2936

Authors: ROILA F BALLATORI E DEANGELIS V TONATO M DELFAVERO A CICCARESE G BASURTO C CICCARESE G PALLADINO MA PORROZZI S PICCIAFUOCO M CONTU A OLMEO N PAZZOLA A PILO L TATEO S CHIAPPARINI I MORANA S LUCCHINO S RICCI S ANTONUZZO A ALLEGRINI G GALLI L CONTE PF MASSIDDA B IONTA MT SCANU A MURRU R PICECE V CIRILLO M MAGAROTTO R NUZZO A LAUDADIO L SABLONE MG LOCATELLI MC DANTONA A LUPORINI G SCAGLIOTTI G SELVAGGI G MATTEI A FAVALLI G GAMBINO A FAVA S GRIMI E SCARFONE G BOLIS MC ALESSANDRONI P CATALANO G BONI C MORETTI G CORTESI E MARTELLI O ANTIMI M BELLINI V BUZZI E BRUGIA M GRECCHI M CLERICO M MONTINARI F DONATI D SANSONI E
Citation: F. Roila et al., DOUBLE-BLIND, DOSE-FINDING STUDY OF 4 INTRAVENOUS DOSES OF DEXAMETHASONE IN THE PREVENTION OF CISPLATIN-INDUCED ACUTE EMESIS, Journal of clinical oncology, 16(9), 1998, pp. 2937-2942

Authors: COCCONI G CUNNINGHAM D VANCUTSEM E FRANCOIS E GUSTAVSSON B VANHAZEL G KERR D POSSINGER K HIETSCHOLD SM
Citation: G. Cocconi et al., OPEN, RANDOMIZED, MULTICENTER TRIAL OF RALTITREXED VERSUS FLUOROURACIL PLUS HIGH-DOSE LEUCOVORIN IN PATIENTS WITH ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 16(9), 1998, pp. 2943-2952

Authors: GALANIS E BUCKNER JC BURCH PA SCHAEFER PL DINAPOLI RP NOVOTNY PJ SCHEITHAUER BW ROWLAND KM VUKOV AM MAILLIARD JA MORTON RF
Citation: E. Galanis et al., PHASE-II TRIAL OF NITROGEN-MUSTARD, VINCRISTINE, AND PROCARBAZINE IN PATIENTS WITH RECURRENT GLIOMA - NORTH CENTRAL CANCER-TREATMENT GROUP RESULTS, Journal of clinical oncology, 16(9), 1998, pp. 2953-2958

Authors: GARCIA AA KERENROSENBERG S PARIMOO D ROGERS M JEFFERS S KODA R MUGGIA FM
Citation: Aa. Garcia et al., PHASE-I AND PHARMACOLOGICAL STUDY OF ESTRAMUSTINE PHOSPHATE AND SHORTINFUSIONS OF PACLITAXEL IN WOMEN WITH SOLID TUMORS, Journal of clinical oncology, 16(9), 1998, pp. 2959-2963

Authors: ROWINSKY EK SMITH L WANG YM CHATURVEDI P VILLALONA M CAMPBELL E AYLESWORTH C ECKHARDT SG HAMMOND L KRAYNAK M DRENGLER R STEPHENSON J HARDING MW VONHOFF DD
Citation: Ek. Rowinsky et al., PHASE-I AND PHARMACOKINETIC STUDY OF PACLITAXEL IN COMBINATION WITH BIRICODAR, A NOVEL AGENT THAT REVERSES MULTIDRUG-RESISTANCE CONFERRED BY OVEREXPRESSION OF BOTH MDR1 AND MRP, Journal of clinical oncology, 16(9), 1998, pp. 2964-2976

Authors: MACKEAN M PLANTING A TWELVES C SCHELLENS J ALLMAN D OSTERWALDER B REIGNER B GRIFFIN T KAYE S VERWEIJ J
Citation: M. Mackean et al., PHASE-I AND PHARMACOLOGICAL STUDY OF INTERMITTENT TWICE-DAILY ORAL-THERAPY WITH CAPECITABINE IN PATIENTS WITH ADVANCED AND OR METASTATIC CANCER/, Journal of clinical oncology, 16(9), 1998, pp. 2977-2985

Authors: SENDEROWICZ AM HEADLEE D STINSON SF LUSH RM KALIL N VILLALBA L HILL K STEINBERG SM FIGG WD TOMPKINS A ARBUCK SG SAUSVILLE EA
Citation: Am. Senderowicz et al., PHASE-I TRIAL OF CONTINUOUS-INFUSION FLAVOPIRIDOL, A NOVEL CYCLIN-DEPENDENT KINASE INHIBITOR, IN PATIENTS WITH REFRACTORY NEOPLASMS, Journal of clinical oncology, 16(9), 1998, pp. 2986-2999

Authors: SANDOR V STARKVANCS V PEARSON D NUSSENBLAT R WHITCUP SM BROUWERS P PATRONAS N HEISS J JAFFE E DESMET M KOHLER D SIMON R WITTES R
Citation: V. Sandor et al., PHASE-II TRIAL OF CHEMOTHERAPY ALONE FOR PRIMARY CNS AND INTRAOCULAR LYMPHOMA, Journal of clinical oncology, 16(9), 1998, pp. 3000-3006

Authors: CHESON BD SORENSEN JM VENA DA MONTELLO MJ BARRET JA DAMASIO E TALLMAN M ANNINO L CONNERS J COIFFIER B LAURIA F
Citation: Bd. Cheson et al., TREATMENT OF HAIRY-CELL LEUKEMIA WITH 2-CHLORODEOXYADENOSINE VIA THE GROUP-C PROTOCOL MECHANISM OF THE NATIONAL-CANCER-INSTITUTE - A REPORTOF 979 PATIENTS, Journal of clinical oncology, 16(9), 1998, pp. 3007-3015

Authors: KUSHNER BH HELLER G CHEUNG NKV WOLLNER N KRAMER K BAJORIN D POLYAK T MEYERS PA
Citation: Bh. Kushner et al., HIGH-RISK OF LEUKEMIA AFTER SHORT-TERM DOSE-INTENSIVE CHEMOTHERAPY INYOUNG-PATIENTS WITH SOLID TUMORS, Journal of clinical oncology, 16(9), 1998, pp. 3016-3020

Authors: SKAPEK SX HAWK BJ HOFFER FA DAHL GV GRANOWETTER L GEBHARDT MC FERGUSON WS GRIER HE
Citation: Sx. Skapek et al., COMBINATION CHEMOTHERAPY USING VINBLASTINE AND METHOTREXATE FOR THE TREATMENT OF PROGRESSIVE DESMOID TUMOR IN CHILDREN, Journal of clinical oncology, 16(9), 1998, pp. 3021-3027

Authors: GERALD WL LADANYI M DEALAVA E CUATRECASAS M KUSHNER BH LAQUAGLIA MP ROSAI J
Citation: Wl. Gerald et al., CLINICAL, PATHOLOGICAL, AND MOLECULAR-SPECTRUM OF TUMORS ASSOCIATED WITH T(11-22)(P13-Q12) - DESMOPLASTIC SMALL ROUND-CELL TUMOR AND ITS VARIANTS, Journal of clinical oncology, 16(9), 1998, pp. 3028-3036

Authors: NICHOLSON HS KRAILO M AMES MM SEIBEL NL REID JM LIUMARES W VEZINA LG ETTINGER AG REAMAN GH
Citation: Hs. Nicholson et al., PHASE-I STUDY OF TEMOZOLOMIDE IN CHILDREN AND ADOLESCENTS WITH RECURRENT SOLID TUMORS - A REPORT FROM THE CHILDRENS CANCER GROUP, Journal of clinical oncology, 16(9), 1998, pp. 3037-3043

Authors: PAULUSSEN M AHRENS S CRAFT AW DUNST J FROHLICH B JABAR S RUBE C WINKELMANN W WISSING S ZOUBEK A JURGENS H
Citation: M. Paulussen et al., EWINGS TUMORS WITH PRIMARY LUNG METASTASES - SURVIVAL ANALYSIS OF 114(EUROPEAN INTERGROUP) COOPERATIVE EWINGS-SARCOMA STUDIES PATIENTS, Journal of clinical oncology, 16(9), 1998, pp. 3044-3052

Authors: CHEUNG NKV KUSHNER BH CHEUNG IY KRAMER K CANETE A GERALD W BONILLA MA FINN R YEH SJ LARSON SM
Citation: Nkv. Cheung et al., ANTI-GD(2) ANTIBODY TREATMENT OF MINIMAL RESIDUAL STAGE-4 NEUROBLASTOMA DIAGNOSED AT MORE THAN 1 YEAR OF AGE, Journal of clinical oncology, 16(9), 1998, pp. 3053-3060

Authors: SOMERS VA PIETERSEN AM THEUNISSEN PH THUNNISSEN FB
Citation: Va. Somers et al., DETECTION OF K-RAS POINT MUTATIONS IN SPUTUM FROM PATIENTS WITH ADENOCARCINOMA OF THE LUNG BY POINT-EXACCT, Journal of clinical oncology, 16(9), 1998, pp. 3061-3068

Authors: PIGNATARO L PRUNERI G CARBONI N CAPACCIO P CESANA BM NERI A BUFFA R
Citation: L. Pignataro et al., CLINICAL RELEVANCE OF CYCLIN D1 PROTEIN OVEREXPRESSION IN LARYNGEAL SQUAMOUS-CELL CARCINOMA, Journal of clinical oncology, 16(9), 1998, pp. 3069-3077

Authors: LAU DH CROWLEY JJ HAZUKA MB ALBAIN KS LEIGH B FLETCHER WS LANIER KS KEISER WL LIVINGSTON RB
Citation: Dh. Lau et al., SOUTHWEST-ONCOLOGY-GROUP PHASE-II TRIAL OF CONCURRENT CARBOPLATIN, ETOPOSIDE, AND RADIATION FOR POOR-RISK STAGE-III NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 16(9), 1998, pp. 3078-3081

Authors: BAILEY AJ PARMAR MKB STEPHENS RJ
Citation: Aj. Bailey et al., PATIENT-REPORTED SHORT-TERM AND LONG-TERM PHYSICAL AND PSYCHOLOGIC SYMPTOMS - RESULTS OF THE CONTINUOUS HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (CHART) RANDOMIZED TRIAL IN NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 16(9), 1998, pp. 3082-3093
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>